Environmental factors and their regulation of immunity in multiple sclerosis

Journal of the Neurological Sciences

Volumn 324, Issue 1-2, 2013, Pages 10-16

  Koch, Marcus W ^a   Metz, Luanne M ^a   Agrawal, Smriti M ^a   Yong, V Wee ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autoimmunity; Epidemiology; Immunology; Multiple sclerosis; Risk factors

Indexed keywords

CD147 ANTIGEN; EXCITOTOXIN; FREE RADICAL; GLUTAMIC ACID; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR; VITAMIN D;

ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LOSS; CLINICAL STUDY; DEMYELINATING DISEASE; DEMYELINATION; DISABILITY; DISEASE ACTIVITY; DISEASE COURSE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS INFECTION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MEASLES; MULTIPLE SCLEROSIS; MUMPS; NERVE CELL LESION; OLIGODENDROGLIA; PARASITOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RUBELLA; SMOKING; SUN EXPOSURE;

ENVIRONMENT; HUMANS; MULTIPLE SCLEROSIS; NUTRITIONAL STATUS; PARASITIC DISEASES; SMOKING; SUNLIGHT; VIRUS DISEASES; VITAMIN D;

EID: 84870913364     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.10.021     Document Type: Review

References (88)

1. A. Ascherio, and K.L. Munger Environmental risk factors for multiple sclerosis. Part II: noninfectious factors Ann Neurol 61 6 Jun 2007 504 513
2. M. Gronning, G. Albrektsen, G. Kvåle, B. Moen, J.A. Aarli, and H. Nyland Organic solvents and multiple sclerosis: a case-control study Acta Neurol Scand 88 4 Oct 1993 247 250
3. J.T. Mortensen, H. Bronnum-Hansen, and K. Rasmussen Multiple sclerosis and organic solvents Epidemiology 9 2 Mar 1998 168 171
4. T. Riise, B.E. Moen, and K.R. Kyvik Organic solvents and the risk of multiple sclerosis Epidemiology 13 6 Nov 2002 718 720
5. B.D. Trapp, and K.-A. Nave Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31 2008 247 269
6. C.M. Kassmann, C. Lappe-Siefke, M. Baes, B. Brügger, A. Mildner, and H.B. Werner Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes Nat Genet 39 8 Aug 2007 969 976
7. V.W. Yong, and S. Marks The interplay between the immune and central nervous systems in neuronal injury Neurology 74 Suppl. 1 Jan 5 2010 S9 S16
8. E. Bettelli, Y. Carrier, W. Gao, T. Korn, T.B. Strom, and M. Oukka Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 7090 May 11 2006 235 238
9. B. Becher, and B.M. Segal T(H)17 cytokines in autoimmune neuro-inflammation Curr Opin Immunol 23 6 Dec 2011 707 712
10. V. Siffrin, H. Radbruch, R. Glumm, R. Niesner, M. Paterka, and J. Herz In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis Immunity 33 3 Sep 24 2010 424 436
11. V. Viglietta, C. Baecher-Allan, H.L. Weiner, and D.A. Hafler Loss of functional suppression by CD4+CD25 + regulatory T cells in patients with multiple sclerosis J Exp Med 199 7 Apr 5 2004 971 979
12. A. Saxena, G. Martin-Blondel, L.T. Mars, and R.S. Liblau Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis FEBS Lett 585 23 Dec 1 2011 3758 3763
13. S.L. Hauser, E. Waubant, D.L. Arnold, T. Vollmer, J. Antel, and R.J. Fox B-cell depletion with rituximab in relapsing-remitting multiple sclerosis N Engl J Med 358 7 Feb 14 2008 676 688
14. L. Kappos, D. Li, P.A. Calabresi, P. O'Connor, A. Bar-Or, and F. Barkhof Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial Lancet 378 9805 Nov 19 2011 1779 1787
15. R. Magliozzi, O. Howell, A. Vora, B. Serafini, R. Nicholas, and M. Puopolo Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology Brain 130 Pt 4 Apr 2007 1089 1104
16. E. Meinl, T. Derfuss, M. Krumbholz, A.-K. Pröbstel, and R. Hohlfeld Humoral autoimmunity in multiple sclerosis J Neurol Sci 306 1-2 Jul 15 2011 180 182
17. H.-C. von Büdingen, A. Bar-Or, and S.S. Zamvil B cells in multiple sclerosis: connecting the dots Curr Opin Immunol 23 6 Dec 2011 713 720
18. S. Agrawal, P. Anderson, M. Durbeej, N. van Rooijen, F. Ivars, and G. Opdenakker Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis J Exp Med 203 4 Apr 17 2006 1007 1019
19. S.M. Agrawal, L. Lau, and V.W. Yong MMPs in the central nervous system: where the good guys go bad Semin Cell Dev Biol 19 1 Feb 2008 42 51
20. S.M. Agrawal, C. Silva, W.W. Tourtellotte, and V.W. Yong EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis J Neurosci 31 2 Jan 12 2011 669 677
21. I. Nikić, D. Merkler, C. Sorbara, M. Brinkoetter, M. Kreutzfeldt, and F.M. Bareyre A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis Nat Med 17 4 Apr 2011 495 499
22. C.R. Gale, and C.N. Martyn Migrant studies in multiple sclerosis Prog Neurobiol 47 4-5 Dec 1995 425 448
23. M. Alter, U. Leibowitz, and J. Speer Risk of multiple sclerosis related to age at immigration to Israel Arch Neurol 15 3 Sep 1966 234 237
24. J.F. Kurtzke, and K. Hyllested Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features Ann Neurol 5 1 Jan 1979 6 21
25. P. Joensen Multiple sclerosis: variation of incidence of onset over time in the Faroe Islands Mult Scler 17 2 Feb 2011 241 244
26. D.C. Poskanzer, J.L. Sheridan, L.B. Prenney, and A.M. Walker Multiple sclerosis in the Orkney and Shetland Islands. II: The search for an exogenous aetiology J Epidemiol Community Health 34 4 Dec 1980 240 252
27. I. Casetta, E. Granieri, S. Malagù, M.R. Tola, E. Paolino, and L.M. Caniatti Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy Neuroepidemiology 13 3 1994 120 128
28. G. Rosati, I. Aiello, E. Granieri, M.I. Pirastru, S. Becciu, and G. Demontis Incidence of multiple sclerosis in Macomer, Sardinia, 1912-1981: onset of the disease after 1950 Neurology 36 1 Jan 1986 14 19
29. A. Ascherio, and K.L. Munger Environmental risk factors for multiple sclerosis. Part I: the role of infection Ann Neurol 61 4 Apr 2007 288 299
30. A.E. Handel, A.J. Williamson, G. Disanto, L. Handunnetthi, G. Giovannoni, and S.V. Ramagopalan An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis PLoS ONE [Internet] 5 9 2010 [cited 2011 Nov 1; Available from: http://www.ncbi.nlm.nih.gov/pubmed/20824132 ]
31. D. Buljevac, G.J.J. van Doornum, H.Z. Flach, J. Groen, A.D.M.E. Osterhaus, and W. Hop Epstein-Barr virus and disease activity in multiple sclerosis J Neurol Neurosurg Psychiatry 76 10 Oct 2005 1377 1381
32. R.A. Farrell, D. Antony, G.R. Wall, D.A. Clark, L. Fisniku, and J. Swanton Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI Neurology 73 1 Jul 7 2009 32 38
33. J.D. Lünemann, M. Tintoré, B. Messmer, T. Strowig, A. Rovira, and H. Perkal Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis Ann Neurol 67 2 Feb 2010 159 169
34. G. Ingram, J.J. Bugert, S. Loveless, and N.P. Robertson Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity Eur J Neurol 17 11 Nov 2010 1386 1389
35. D. Pohl, K. Rostasy, C. Jacobi, P. Lange, R. Nau, and B. Krone Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis J Neurol 257 2 Feb 2010 212 216
36. C. Otto, A. Oltmann, A. Stein, K. Frenzel, J. Schroeter, and P. Habbel Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis Neurology 76 15 Apr 12 2011 1316 1321
37. K. Kakalacheva, C. Münz, and J.D. Lünemann Viral triggers of multiple sclerosis Biochim Biophys Acta 1812 2 Feb 2011 132 140
38. M. Sospedra, and R. Martin Immunology of multiple sclerosis Annu Rev Immunol 23 2005 683 747
39. J.E. Libbey, L.L. McCoy, and R.S. Fujinami Molecular mimicry in multiple sclerosis Int Rev Neurobiol 79 2007 127 147
40. E.M.L. Chastain, and S.D. Miller Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease Immunol Rev 245 1 Jan 2012 227 238
41. P.J. Talbot, J.S. Paquette, C. Ciurli, J.P. Antel, and F. Ouellet Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis Ann Neurol 39 2 Feb 1996 233 240
42. W. Cheng, Y. Ma, F. Gong, C. Hu, L. Qian, and Q. Huang Cross-reactivity of autoreactive T cells with MBP and viral antigens in patients with MS Front Biosci 17 2012 1648 1658
43. H.L.E. Lang, H. Jacobsen, S. Ikemizu, C. Andersson, K. Harlos, and L. Madsen A functional and structural basis for TCR cross-reactivity in multiple sclerosis Nat Immunol 3 10 Oct 2002 940 943
44. B. Serafini, M. Severa, S. Columba-Cabezas, B. Rosicarelli, C. Veroni, and G. Chiappetta Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation J Neuropathol Exp Neurol 69 7 Jul 2010 677 693
45. U.-C. Meier, G. Giovannoni, J.S. Tzartos, and G. Khan Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system? Clin Exp Immunol 167 1 Jan 2012 1 6
46. A.G. Gabibov, A.A. Belogurov Jr., Y.A. Lomakin, M.Y. Zakharova, M.E. Avakyan, and V.V. Dubrovskaya Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen FASEB J 25 12 Dec 2011 4211 4221
47. S. Jilek, M. Schluep, A. Harari, M. Canales, A. Lysandropoulos, and A. Zekeridou HLA-B7-restricted EBV-specific CD8 + T cells are dysregulated in multiple sclerosis J Immunol 188 9 May 1 2012 4671 4680
48. M.P. Pender CD8 + T-cell deficiency, Epstein-Barr Virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis Autoimmune Dis 2012 2012 189096
49. J. Correale, and M. Farez Association between parasite infection and immune responses in multiple sclerosis Ann Neurol 61 2 Feb 2007 97 108
50. J. Correale, and M.F. Farez The impact of parasite infections on the course of multiple sclerosis J Neuroimmunol 233 1-2 Apr 2011 6 11
51. J. Fleming, A. Isaak, J. Lee, C. Luzzio, M. Carrithers, and T. Cook Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study Mult Scler 17 6 Jun 2011 743 754
52. J. Correale, M. Farez, and G. Razzitte Helminth infections associated with multiple sclerosis induce regulatory B cells Ann Neurol 64 2 Aug 2008 187 199
53. M.A. Hernán, M.J. Olek, and A. Ascherio Cigarette smoking and incidence of multiple sclerosis Am J Epidemiol 154 1 Jul 1 2001 69 74
54. Y. Mikaeloff, G. Caridade, M. Tardieu, and S. Suissa Parental smoking at home and the risk of childhood-onset multiple sclerosis in children Brain 130 Pt 10 Oct 2007 2589 2595
55. A. Hedström, M. Bäärnhielm, T. Olsson, and L. Alfredsson Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis Mult Scler 17 7 Jul 2011 788 793
56. F. Di Pauli, M. Reindl, R. Ehling, F. Schautzer, C. Gneiss, and A. Lutterotti Smoking is a risk factor for early conversion to clinically definite multiple sclerosis Mult Scler 14 8 Sep 2008 1026 1030
57. R. Zivadinov, B. Weinstock-Guttman, K. Hashmi, N. Abdelrahman, M. Stosic, and M. Dwyer Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis Neurology 73 7 Aug 18 2009 504 510
58. B.C. Healy, E.N. Ali, C.R.G. Guttmann, T. Chitnis, B.I. Glanz, and G. Buckle Smoking and disease progression in multiple sclerosis Arch Neurol 66 7 Jul 2009 858 864
59. M. Koch, A. van Harten, M. Uyttenboogaart, and J. De Keyser Cigarette smoking and progression in multiple sclerosis Neurology 69 15 Oct 9 2007 1515 1520
60. M.A. Hernán, S.S. Jick, G. Logroscino, M.J. Olek, A. Ascherio, and H. Jick Cigarette smoking and the progression of multiple sclerosis Brain 128 Pt 6 Jun 2005 1461 1465
61. F. Pittas, A.-L. Ponsonby, I.A.F. van der Mei, B.V. Taylor, L. Blizzard, and P. Groom Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis J Neurol 256 4 2009 577 585
62. R.B. Gonçalves, R.D. Coletta, K.G. Silvério, L. Benevides, M.Z. Casati, and J.S. da Silva Impact of smoking on inflammation: overview of molecular mechanisms Inflamm Res 60 5 May 2011 409 424
63. A.K. Hedström, E. Sundqvist, M. Bäärnhielm, N. Nordin, J. Hillert, and I. Kockum Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis Brain 134 Pt 3 Mar 2011 653 664
64. F.J. Quintana, A.S. Basso, A.H. Iglesias, T. Korn, M.F. Farez, and E. Bettelli Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor Nature 453 7191 May 1 2008 65 71
65. O. Ozçaka, N. Biçakci, P. Pussinen, T. Sorsa, T. Köse, and N. Buduneli Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis Oral Dis 17 1 Jan 2011 68 76
66. S. Simpson Jr., L. Blizzard, P. Otahal, I. Van der Mei, and B. Taylor Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis J Neurol Neurosurg Psychiatry 82 10 2011 1132 1141
67. A. Ascherio, K.L. Munger, and K.C. Simon Vitamin D and multiple sclerosis Lancet Neurol 9 6 Jun 2010 599 612
68. I.A.F. van der Mei, A.-L. Ponsonby, T. Dwyer, L. Blizzard, R. Simmons, and B.V. Taylor Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study BMJ 327 7410 2003 316
69. K.L. Munger, L.I. Levin, B.W. Hollis, N.S. Howard, and A. Ascherio Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis JAMA 296 23 Dec 20 2006 2832 2838
70. S. Sloka, C. Silva, W. Pryse-Phillips, S. Patten, L. Metz, and V.W. Yong A quantitative analysis of suspected environmental causes of MS Can J Neurol Sci 38 1 Jan 2011 98 105
71. J. Nieves, F. Cosman, J. Herbert, V. Shen, and R. Lindsay High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis Neurology 44 9 Sep 1994 1687 1692
72. J. Smolders, P. Menheere, A. Kessels, J. Damoiseaux, and R. Hupperts Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis Mult Scler 14 9 Nov 2008 1220 1224
73. S. Simpson, B. Taylor, L. Blizzard, A.-L. Ponsonby, F. Pittas, and H. Tremlett Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis Ann Neurol 68 2 Aug 2010 193 203
74. E.M. Mowry, L.B. Krupp, M. Milazzo, D. Chabas, J.B. Strober, and A.L. Belman Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis Ann Neurol 67 5 May 2010 618 624
75. J.M. Burton, S. Kimball, R. Vieth, A. Bar-Or, H.-M. Dosch, and R. Cheung A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis Neurology 74 23 Jun 8 2010 1852 1859
76. P.H. Hart, S. Gorman, and J.J. Finlay-Jones Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol 11 9 Sep 2011 584 596
77. S.V. Ramagopalan, D.A. Dyment, M.Z. Cader, K.M. Morrison, G. Disanto, and J.M. Morahan Rare variants in the CYP27B1 gene are associated with multiple sclerosis Ann Neurol 70 6 Dec 2011 881 886
78. S. Sawcer, G. Hellenthal, M. Pirinen, C.C.A. Spencer, N.A. Patsopoulos, and L. Moutsianas Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 7359 Aug 11 2011 214 219
79. S.V. Ramagopalan, N.J. Maugeri, L. Handunnetthi, M.R. Lincoln, S.-M. Orton, and D.A. Dyment Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D PLoS Genet 5 2 Feb 2009 e1000369
80. L. Széles, G. Keresztes, D. Töröcsik, Z. Balajthy, L. Krenács, and S. Póliska 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype J Immunol 182 4 Feb 15 2009 2074 2083
81. J. Correale, M.C. Ysrraelit, and M.I. Gaitán Immunomodulatory effects of Vitamin D in multiple sclerosis Brain 132 Pt 5 May 2009 1146 1160
82. S. Sloka, C. Silva, J. Wang, and V.W. Yong Predominance of Th2 polarization by Vitamin D through a STAT6-dependent mechanism J Neuroinflammation 8 2011 56
83. C. Almerighi, A. Sinistro, A. Cavazza, C. Ciaprini, G. Rocchi, and A. Bergamini 1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes Cytokine 45 3 Mar 2009 190 197
84. J.M. Lemire, and D.C. Archer 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis J Clin Invest 87 3 Mar 1991 1103 1107
85. M.T. Cantorna, C.E. Hayes, and H.F. DeLuca 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis Proc Natl Acad Sci U S A 93 15 Jul 23 1996 7861 7864
86. J. Smolders, S.M. Moen, J. Damoiseaux, I. Huitinga, and T. Holmoy Vitamin D in the healthy and inflamed central nervous system: access and function J Neurol Sci 311 1-2 Dec 15 2011 37 43
87. D.A. Fernandes de Abreu, E. Nivet, N. Baril, M. Khrestchatisky, F. Roman, and F. Féron Developmental vitamin D deficiency alters learning in C57Bl/6J mice Behav Brain Res 208 2 Apr 2 2010 603 608
88. L.D. Brewer, V. Thibault, K.C. Chen, M.C. Langub, P.W. Landfield, and N.M. Porter Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons J Neurosci 21 1 2001 Jan 1 98 108